Compounds > glutamine

glutamine and B-Cell Chronic Lymphocytic Leukemia

glutamine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bryant, DJ; Chen, Z; Cretenet, G; Eldering, E; Forconi, F; Kater, AP; Packham, G; Peters, FS; Rathmell, JC; Schomakers, BV; Simon-Molas, H; Smith, LD; Valle-Argos, B; van Bruggen, JAC; van der Windt, GJW; van Weeghel, M1
Deaglio, S1
Castegna, A; De Tullio, G; Ghesquière, B; Guarini, A; Hooper, DC; Lamers, WH; Martín-Pérez, R; Mazzone, M; McVicar, DW; Menga, A; Palmieri, EM; Quinto, A; Riera-Domingo, C1
Aloyz, R; Galicia-Vázquez, G; Smith, S1
Al-Zebeeby, A; Alotibi, A; Cohen, GM; Dyer, MJS; Greaves, G; Milani, M; Richards, C; Varadarajan, S; Vogler, M1

Other Studies

5 other study(ies) available for glutamine and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment.
    Blood, 2022, 08-11, Volume: 140, Issue:6

    Topics: CD40 Antigens; Glucose; Glutamine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Receptors, Antigen, B-Cell; Tumor Microenvironment

2022
Glutamine and CLL: ready for prime time?
    Blood, 2022, 08-11, Volume: 140, Issue:6

    Topics: Glutamine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymph Nodes; Tumor Microenvironment

2022
Pharmacologic or Genetic Targeting of Glutamine Synthetase Skews Macrophages toward an M1-like Phenotype and Inhibits Tumor Metastasis.
    Cell reports, 2017, 08-15, Volume: 20, Issue:7

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Cell Movement; Endothelial Cells; Enzyme Inhibitors; Glucose; Glutamate-Ammonia Ligase; Glutamine; Glycolysis; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Injections, Subcutaneous; Interleukin-10; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Macrophages; Methionine Sulfoximine; Mice; Mice, Knockout; Monocytes; Neovascularization, Pathologic; Primary Cell Culture; Succinic Acid; T-Lymphocytes, Cytotoxic

2017
Del11q-positive CLL lymphocytes exhibit altered glutamine metabolism and differential response to GLS1 and glucose metabolism inhibition.
    Blood cancer journal, 2018, 01-24, Volume: 8, Issue:1

    Topics: Chromosome Deletion; Chromosomes, Human, Pair 11; Female; Glucose; Glutaminase; Glutamine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male

2018
Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies.
    Haematologica, 2019, Volume: 104, Issue:5

    Topics: Antineoplastic Agents; bcl-X Protein; Benzothiazoles; Biomimetics; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Drug Resistance, Neoplasm; Glutamine; Humans; Indoles; Isoquinolines; Leukemia, Lymphocytic, Chronic, B-Cell; Lipogenesis; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Recurrence, Local; Peptide Fragments; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; TOR Serine-Threonine Kinases; Tumor Cells, Cultured

2019